PDB Short entry for 5ZBQ HEADER SIGNALING PROTEIN 12-FEB-18 5ZBQ TITLE THE CRYSTAL STRUCTURE OF HUMAN NEUROPEPTIDE Y Y1 RECEPTOR WITH UR- TITLE 2 MK299 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1,T4 LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 2-358,UNP RESIDUES 2-161; COMPND 5 SYNONYM: NPY1-R,LYSIS PROTEIN,LYSOZYME,MURAMIDASE; COMPND 6 EC: 3.2.1.17; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE RB55; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 697289; SOURCE 5 GENE: NPY1R, NPYR, NPYY1, E, RB55_P125; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS G PROTEIN-COUPLED RECEPTOR, RECEPTOR INHIBITOR, COMPLEX STRUCTURE, KEYWDS 2 SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.YANG,S.HAN,Q.ZHAO,B.WU REVDAT 3 09-MAY-18 5ZBQ 1 JRNL REVDAT 2 02-MAY-18 5ZBQ 1 JRNL REVDAT 1 25-APR-18 5ZBQ 0 JRNL AUTH Z.YANG,S.HAN,M.KELLER,A.KAISER,B.J.BENDER,M.BOSSE,K.BURKERT, JRNL AUTH 2 L.M.KOGLER,D.WIFLING,G.BERNHARDT,N.PLANK,T.LITTMANN, JRNL AUTH 3 P.SCHMIDT,C.YI,B.LI,S.YE,R.ZHANG,B.XU,D.LARHAMMAR, JRNL AUTH 4 R.C.STEVENS,D.HUSTER,J.MEILER,Q.ZHAO,A.G.BECK-SICKINGER, JRNL AUTH 5 A.BUSCHAUER,B.WU JRNL TITL STRUCTURAL BASIS OF LIGAND BINDING MODES AT THE NEUROPEPTIDE JRNL TITL 2 Y Y1RECEPTOR JRNL REF NATURE V. 556 520 2018 JRNL REFN ESSN 1476-4687 JRNL PMID 29670288 JRNL DOI 10.1038/S41586-018-0046-X REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 16520 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.780 REMARK 3 FREE R VALUE TEST SET COUNT : 790 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.89 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.40 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2949 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2260 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2818 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.44 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3715 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 78.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 87.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.13210 REMARK 3 B22 (A**2) : -31.82530 REMARK 3 B33 (A**2) : 17.69320 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.13980 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.470 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.745 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.306 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.974 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.320 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.876 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3850 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5229 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1308 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 78 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 557 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3850 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 512 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4577 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.25 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -50.2552 -14.9395 95.5975 REMARK 3 T TENSOR REMARK 3 T11: 0.0000 T22: 0.0000 REMARK 3 T33: 0.0000 T12: 0.0000 REMARK 3 T13: 0.0000 T23: 0.0000 REMARK 3 L TENSOR REMARK 3 L11: 0.0000 L22: 0.0000 REMARK 3 L33: 0.0000 L12: 0.0000 REMARK 3 L13: 0.0000 L23: 0.0000 REMARK 3 S TENSOR REMARK 3 S11: 0.0000 S12: 0.0000 S13: 0.0000 REMARK 3 S21: 0.0000 S22: 0.0000 S23: 0.0000 REMARK 3 S31: 0.0000 S32: 0.0000 S33: 0.0000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ZBQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1300006805. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JAN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16689 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.970 REMARK 200 R MERGE (I) : 0.16600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.7800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.64 REMARK 200 R MERGE FOR SHELL (I) : 0.93700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4GRV, 1C5P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, PH 7.4-8.0, 30-40% (V/V) REMARK 280 PEG400, 50-150 MM SODIUM TARTRATE AND 100 UM UR-MK299, LIPIDIC REMARK 280 CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.34000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS NUKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 2 REMARK 465 SER A 3 REMARK 465 THR A 4 REMARK 465 LEU A 5 REMARK 465 PHE A 6 REMARK 465 SER A 7 REMARK 465 GLN A 8 REMARK 465 VAL A 9 REMARK 465 GLU A 10 REMARK 465 ASN A 11 REMARK 465 HIS A 12 REMARK 465 SER A 13 REMARK 465 VAL A 14 REMARK 465 HIS A 15 REMARK 465 SER A 16 REMARK 465 ASN A 17 REMARK 465 ASN A 242 REMARK 465 ASN A 243 REMARK 465 MET A 244 REMARK 465 MET A 245 REMARK 465 ASP A 246 REMARK 465 LYS A 247 REMARK 465 MET A 248 REMARK 465 ARG A 249 REMARK 465 ASP A 250 REMARK 465 ASN A 251 REMARK 465 LYS A 252 REMARK 465 TYR A 253 REMARK 465 ARG A 254 REMARK 465 SER A 255 REMARK 465 CYS A 338 REMARK 465 ASP A 339 REMARK 465 PHE A 340 REMARK 465 ARG A 341 REMARK 465 SER A 342 REMARK 465 ARG A 343 REMARK 465 ASP A 344 REMARK 465 ASP A 345 REMARK 465 ASP A 346 REMARK 465 TYR A 347 REMARK 465 GLU A 348 REMARK 465 THR A 349 REMARK 465 ILE A 350 REMARK 465 ALA A 351 REMARK 465 MET A 352 REMARK 465 SER A 353 REMARK 465 THR A 354 REMARK 465 MET A 355 REMARK 465 HIS A 356 REMARK 465 THR A 357 REMARK 465 ASP A 358 REMARK 465 GLU A 359 REMARK 465 PHE A 360 REMARK 465 LEU A 361 REMARK 465 GLU A 362 REMARK 465 VAL A 363 REMARK 465 LEU A 364 REMARK 465 PHE A 365 REMARK 465 GLN A 366 REMARK 465 LEU A 1132 REMARK 465 ALA A 1133 REMARK 465 LYS A 1134 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 18 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 20 CG CD OE1 OE2 REMARK 470 LYS A 21 CG CD CE NZ REMARK 470 GLU A 29 CG CD OE1 OE2 REMARK 470 ASN A 30 CG OD1 ND2 REMARK 470 ASP A 32 CG OD1 OD2 REMARK 470 GLU A 182 CG CD OE1 OE2 REMARK 470 LYS A 193 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C ARG A 241 N ASN A 1001 1.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 29 58.20 -165.00 REMARK 500 CYS A 93 -71.85 -112.85 REMARK 500 LEU A 94 -55.91 -27.96 REMARK 500 HIS A 105 134.31 -178.14 REMARK 500 ASN A 144 66.21 -118.59 REMARK 500 TRP A 148 54.34 29.12 REMARK 500 THR A 188 -105.22 52.92 REMARK 500 ALA A 191 66.82 -163.63 REMARK 500 TYR A 220 -80.52 -125.31 REMARK 500 ASN A 289 60.98 -111.00 REMARK 500 ASP A1019 -169.62 -76.45 REMARK 500 PHE A1113 52.69 -91.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9AO A 1301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ZBH RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THE SITE (359-366) IS THE PRESCISSION PROTEASE REMARK 999 SITE CONNECTED TO THE C TERMINAL OF THE RECEPTOR. DBREF 5ZBQ A 2 358 UNP P25929 NPY1R_HUMAN 2 358 DBREF1 5ZBQ A 1001 1160 UNP A0A097J792_BPT4 DBREF2 5ZBQ A A0A097J792 2 161 SEQADV 5ZBQ TRP A 129 UNP P25929 PHE 129 ENGINEERED MUTATION SEQADV 5ZBQ GLU A 359 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ PHE A 360 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ LEU A 361 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ GLU A 362 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ VAL A 363 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ LEU A 364 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ PHE A 365 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ GLN A 366 UNP P25929 SEE SEQUENCE DETAILS SEQADV 5ZBQ THR A 1053 UNP A0A097J79 CYS 54 ENGINEERED MUTATION SEQADV 5ZBQ ALA A 1096 UNP A0A097J79 CYS 97 ENGINEERED MUTATION SEQRES 1 A 525 ASN SER THR LEU PHE SER GLN VAL GLU ASN HIS SER VAL SEQRES 2 A 525 HIS SER ASN PHE SER GLU LYS ASN ALA GLN LEU LEU ALA SEQRES 3 A 525 PHE GLU ASN ASP ASP CYS HIS LEU PRO LEU ALA MET ILE SEQRES 4 A 525 PHE THR LEU ALA LEU ALA TYR GLY ALA VAL ILE ILE LEU SEQRES 5 A 525 GLY VAL SER GLY ASN LEU ALA LEU ILE ILE ILE ILE LEU SEQRES 6 A 525 LYS GLN LYS GLU MET ARG ASN VAL THR ASN ILE LEU ILE SEQRES 7 A 525 VAL ASN LEU SER PHE SER ASP LEU LEU VAL ALA ILE MET SEQRES 8 A 525 CYS LEU PRO PHE THR PHE VAL TYR THR LEU MET ASP HIS SEQRES 9 A 525 TRP VAL PHE GLY GLU ALA MET CYS LYS LEU ASN PRO PHE SEQRES 10 A 525 VAL GLN CYS VAL SER ILE THR VAL SER ILE TRP SER LEU SEQRES 11 A 525 VAL LEU ILE ALA VAL GLU ARG HIS GLN LEU ILE ILE ASN SEQRES 12 A 525 PRO ARG GLY TRP ARG PRO ASN ASN ARG HIS ALA TYR VAL SEQRES 13 A 525 GLY ILE ALA VAL ILE TRP VAL LEU ALA VAL ALA SER SER SEQRES 14 A 525 LEU PRO PHE LEU ILE TYR GLN VAL MET THR ASP GLU PRO SEQRES 15 A 525 PHE GLN ASN VAL THR LEU ASP ALA TYR LYS ASP LYS TYR SEQRES 16 A 525 VAL CYS PHE ASP GLN PHE PRO SER ASP SER HIS ARG LEU SEQRES 17 A 525 SER TYR THR THR LEU LEU LEU VAL LEU GLN TYR PHE GLY SEQRES 18 A 525 PRO LEU CYS PHE ILE PHE ILE CYS TYR PHE LYS ILE TYR SEQRES 19 A 525 ILE ARG LEU LYS ARG ARG ASN ASN MET MET ASP LYS MET SEQRES 20 A 525 ARG ASP ASN LYS TYR ARG SER SER GLU THR LYS ARG ILE SEQRES 21 A 525 ASN ILE MET LEU LEU SER ILE VAL VAL ALA PHE ALA VAL SEQRES 22 A 525 CYS TRP LEU PRO LEU THR ILE PHE ASN THR VAL PHE ASP SEQRES 23 A 525 TRP ASN HIS GLN ILE ILE ALA THR CYS ASN HIS ASN LEU SEQRES 24 A 525 LEU PHE LEU LEU CYS HIS LEU THR ALA MET ILE SER THR SEQRES 25 A 525 CYS VAL ASN PRO ILE PHE TYR GLY PHE LEU ASN LYS ASN SEQRES 26 A 525 PHE GLN ARG ASP LEU GLN PHE PHE PHE ASN PHE CYS ASP SEQRES 27 A 525 PHE ARG SER ARG ASP ASP ASP TYR GLU THR ILE ALA MET SEQRES 28 A 525 SER THR MET HIS THR ASP GLU PHE LEU GLU VAL LEU PHE SEQRES 29 A 525 GLN ASN ILE PHE GLU MET LEU ARG ILE ASP GLU GLY LEU SEQRES 30 A 525 ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR TYR THR SEQRES 31 A 525 ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SER LEU SEQRES 32 A 525 ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE GLY ARG SEQRES 33 A 525 ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA GLU LYS SEQRES 34 A 525 LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE SEQRES 35 A 525 LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SER LEU SEQRES 36 A 525 ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET VAL PHE SEQRES 37 A 525 GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR ASN SER SEQRES 38 A 525 LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA SEQRES 39 A 525 VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN THR PRO SEQRES 40 A 525 ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG THR GLY SEQRES 41 A 525 THR TRP ASP ALA TYR HET 9AO A1301 45 HETNAM 9AO N~2~-(DIPHENYLACETYL)-N-[(4-HYDROXYPHENYL)METHYL]-N~5~- HETNAM 2 9AO (N'-{[2-(PROPANOYLAMINO) HETNAM 3 9AO ETHYL]CARBAMOYL}CARBAMIMIDOYL)-D-ORNITHINAMIDE FORMUL 2 9AO C33 H41 N7 O5 HELIX 1 AA1 LYS A 21 LEU A 25 5 5 HELIX 2 AA2 PRO A 36 GLN A 68 1 33 HELIX 3 AA3 ASN A 73 CYS A 93 1 21 HELIX 4 AA4 CYS A 93 ASP A 104 1 12 HELIX 5 AA5 GLY A 109 ILE A 143 1 35 HELIX 6 AA6 ASN A 151 TYR A 176 1 26 HELIX 7 AA7 ASP A 181 GLN A 185 5 5 HELIX 8 AA8 SER A 204 TYR A 220 1 17 HELIX 9 AA9 TYR A 220 ARG A 241 1 22 HELIX 10 AB1 THR A 258 ASN A 289 1 32 HELIX 11 AB2 THR A 295 PHE A 322 1 28 HELIX 12 AB3 ASN A 324 PHE A 335 1 12 HELIX 13 AB4 ILE A 1002 GLU A 1010 1 9 HELIX 14 AB5 SER A 1037 GLY A 1050 1 14 HELIX 15 AB6 THR A 1058 ASN A 1080 1 23 HELIX 16 AB7 LYS A 1082 LEU A 1090 1 9 HELIX 17 AB8 ASP A 1091 MET A 1105 1 15 HELIX 18 AB9 GLY A 1106 ALA A 1111 1 6 HELIX 19 AC1 PHE A 1113 GLN A 1122 1 10 HELIX 20 AC2 ARG A 1124 ASN A 1131 1 8 HELIX 21 AC3 ARG A 1136 THR A 1141 1 6 HELIX 22 AC4 THR A 1141 GLY A 1155 1 15 SHEET 1 AA1 2 ALA A 27 PHE A 28 0 SHEET 2 AA1 2 ILE A 293 ALA A 294 1 O ALA A 294 N ALA A 27 SHEET 1 AA2 2 GLN A 177 THR A 180 0 SHEET 2 AA2 2 VAL A 197 ASP A 200 -1 O VAL A 197 N THR A 180 SHEET 1 AA3 3 ARG A1013 LYS A1018 0 SHEET 2 AA3 3 TYR A1024 GLY A1027 -1 O THR A1025 N TYR A1017 SHEET 3 AA3 3 HIS A1030 THR A1033 -1 O LEU A1032 N TYR A1024 SSBOND 1 CYS A 33 CYS A 296 1555 1555 2.05 SSBOND 2 CYS A 113 CYS A 198 1555 1555 2.04 CISPEP 1 ASP A 190 ALA A 191 0 -1.45 SITE 1 AC1 13 PRO A 117 GLN A 120 CYS A 121 ILE A 124 SITE 2 AC1 13 PHE A 173 THR A 212 GLN A 219 THR A 280 SITE 3 AC1 13 PHE A 282 ASN A 283 PHE A 286 ASP A 287 SITE 4 AC1 13 PHE A 302 CRYST1 37.840 100.680 83.160 90.00 98.76 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026427 0.000000 0.004072 0.00000 SCALE2 0.000000 0.009932 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012167 0.00000